Northern Trust Corp Neurocrine Biosciences Inc Transaction History

Northern Trust Corp

  • $761 Billion
  • Q3 2025

A detailed history of Northern Trust Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Northern Trust Corp holds 925,714 shares of NBIX stock, worth $134 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
925,714
Previous 929,058 0.36%
Holding current value
$134 Million
Previous $117 Million 11.29%
% of portfolio
0.02%
Previous 0.02%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$123.98 - $146.67 $414,589 - $490,464
-3,344 Reduced 0.36%
925,714 $130 Million
Q2 2025

Aug 13, 2025
SELL
$87.54 - $128.18 $2.47 Million - $3.62 Million
-28,222 Reduced 2.95%
929,058 $117 Million
Q1 2025

May 13, 2025
SELL
$107.22 - $153.29 $2.64 Million - $3.78 Million
-24,659 Reduced 2.51%
957,280 $106 Million
Q4 2024

Feb 14, 2025
BUY
$111.62 - $139.44 $23.5 Million - $29.3 Million
210,315 Added 27.26%
981,939 $134 Million
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $4.47 Million - $5.97 Million
-38,996 Reduced 4.81%
771,624 $88.8 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $12.5 Million - $13.7 Million
95,552 Added 13.36%
810,620 $112 Million
Q1 2024

May 14, 2024
SELL
$130.4 - $143.74 $12 Million - $13.3 Million
-92,213 Reduced 11.42%
715,068 $98.6 Million
Q4 2023

Feb 13, 2024
SELL
$106.07 - $132.76 $3.83 Million - $4.79 Million
-36,062 Reduced 4.28%
807,281 $106 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $457,783 - $570,159
-4,869 Reduced 0.57%
843,343 $94.9 Million
Q2 2023

Aug 11, 2023
SELL
$89.53 - $104.87 $2.45 Million - $2.87 Million
-27,398 Reduced 3.13%
848,212 $80 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $1.32 Million - $1.73 Million
14,068 Added 1.63%
875,610 $88.6 Million
Q4 2022

Feb 13, 2023
BUY
$106.72 - $127.06 $361,460 - $430,352
3,387 Added 0.39%
861,542 $103 Million
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $1.12 Million - $1.31 Million
-12,167 Reduced 1.4%
858,155 $91.1 Million
Q2 2022

Aug 12, 2022
SELL
$75.79 - $100.07 $967,762 - $1.28 Million
-12,769 Reduced 1.45%
870,322 $84.8 Million
Q1 2022

May 13, 2022
BUY
$72.45 - $94.81 $628,866 - $822,950
8,680 Added 0.99%
883,091 $82.8 Million
Q4 2021

Feb 08, 2022
SELL
$79.65 - $106.22 $3.14 Million - $4.18 Million
-39,388 Reduced 4.31%
874,411 $74.5 Million
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $1.55 Million - $1.78 Million
17,940 Added 2.0%
913,799 $87.6 Million
Q2 2021

Aug 13, 2021
SELL
$89.43 - $102.27 $5.83 Million - $6.66 Million
-65,144 Reduced 6.78%
895,859 $87.2 Million
Q1 2021

May 12, 2021
BUY
$87.57 - $119.4 $28.6 Million - $39.1 Million
327,101 Added 51.6%
961,003 $93.5 Million
Q4 2020

Feb 11, 2021
SELL
$86.91 - $108.33 $715,530 - $891,880
-8,233 Reduced 1.28%
633,902 $60.8 Million
Q3 2020

Nov 16, 2020
SELL
$96.16 - $135.15 $3.52 Million - $4.94 Million
-36,572 Reduced 5.39%
642,135 $61.7 Million
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $6.99 Million - $10.7 Million
82,118 Added 13.76%
678,707 $82.8 Million
Q1 2020

May 14, 2020
BUY
$75.11 - $113.76 $3.3 Million - $5 Million
43,924 Added 7.95%
596,589 $51.6 Million
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $9.72 Million - $13.3 Million
112,033 Added 25.43%
552,665 $59.4 Million
Q3 2019

Nov 13, 2019
SELL
$83.82 - $101.5 $522,282 - $632,446
-6,231 Reduced 1.39%
440,632 $39.7 Million
Q2 2019

Aug 13, 2019
BUY
$72.24 - $91.27 $11,702 - $14,785
162 Added 0.04%
446,863 $37.7 Million
Q1 2019

May 13, 2019
BUY
$69.31 - $91.53 $413,919 - $546,617
5,972 Added 1.36%
446,701 $39.4 Million
Q4 2018

Feb 12, 2019
BUY
$68.32 - $124.36 $75,151 - $136,796
1,100 Added 0.25%
440,729 $31.5 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $841,172 - $1.07 Million
-8,507 Reduced 1.9%
439,629 $54.1 Million
Q2 2018

Sep 18, 2018
SELL
$75.3 - $105.99 $421,604 - $593,438
-5,599 Reduced 1.23%
448,136 $44 Million
Q2 2018

Aug 14, 2018
SELL
$75.3 - $105.99 $2.26 Million - $3.19 Million
-30,066 Reduced 6.21%
453,735 $44.6 Million
Q1 2018

May 09, 2018
BUY
$75.88 - $92.43 $1.17 Million - $1.42 Million
15,395 Added 3.29%
483,801 $40.1 Million
Q4 2017

Feb 14, 2018
BUY
$58.53 - $77.59 $437,511 - $579,985
7,475 Added 1.62%
468,406 $36.3 Million
Q3 2017

Nov 13, 2017
BUY
$47.97 - $61.28 $22.1 Million - $28.2 Million
460,931
460,931 $28.2 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email